Baku 14° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
17:34
Marta Kos: EU proposes creation of quadripartite group to develop Middle Corridor
Infrastructure17:29
Sahil Babayev: At least 95% of population to be fully covered by mandatory health insurance
Finance17:16
Borrell named among suspects in College of Europe fraud case
Other countries17:12
Photo
Azerbaijan discusses co-op with Turkish pharmaceutical company
Business17:00
Ambassador: Seoul and Baku have good opportunities for cooperation in agri-industrial sector
AIC16:47
Kallas: EU ready to take serious steps to support peace process in South Caucasus
Region16:41
Photo
Azerbaijan participates in maritime seminar in Portugal
Infrastructure16:36
Sahil Babayev: Azerbaijan expanding tax incentives, strengthening assessment of their effectiveness
Finance16:35
Photo